Blocks post‑amputation pain via implantable nerve stimulation to empower patient‑controlled relief.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Neuros Medical develops and commercializes a patient‑controlled implantable nerve stimulation system to manage chronic pain in individuals with limb loss. The Altius® device delivers targeted electrical pulses directly to affected nerves to block pain signals, offering a non‑opioid alternative that empowers users to initiate relief on demand.
Neuros Medical Funding
Sign up to gain insights into Neuros Medical funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series D | Jul 09, 2025 | 56M | ||
| Series D | Oct 27, 2020 | 37M | ||
| Series C | Oct 11, 2019 | 2M | ||
| Series C | Aug 03, 2017 | 23M | ||
| Series A | Nov 22, 2011 | 3M | ||
| Series A | Aug 20, 2009 | 1M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Neuros Medical Management Team
Investors
JumpStart
Aperture Venture Partners
Sectoral Asset Management
EQT Ventures
Boston Scientific Corp
U.S. Venture Partners
Amzak Health
Osage University Partners
Neuros Medical Valuations & Financials
View real-time NPM data on Neuros Medical stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Neuros Medical
Tonal
Health Care
Delivers AI-powered strength training with digital weights and personalized coaching.
Curology
Health Care
Offers personalized prescription skin care medications delivered directly to you.
Devoted
Health Care
Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.
Cerebral
Health Care
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Virta Health
Health Care
Online specialty medical clinic focused on reversing type 2 diabetes.
Color Genomics
Health Care
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Cityblock Health
Health Care
Tech-driven care provider for communities with complex needs.
FAQ
We have answers
Neuros Medical stock does not trade on public stock exchanges. Neuros Medical stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Neuros Medical stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Neuros Medical Stock does not trade on public stock exchanges. In order to sell Neuros Medical shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Neuros Medical does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Neuros Medical share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Neuros Medical stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Neuros Medical stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Neuros Medical stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Neuros Medical is a private company and has not had an IPO. There is currently no Neuros Medical IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Neuros Medical IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
